as of this month, there are 56 companies in china involved in the commercialization of car cell therapies
. taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.
.
.
.
plemmons and co-authors disclosed no relevant relationships with industry.
.
.
.